Alternative splicing is now commonly thought to affect more than half of all human genes. Recent studies have investigated not only the scope but also the biological impact of alternative splicing on a large scale, revealing that its role in generating proteome diversity may be augmented by a role in regulation. For instance, protein function can be regulated by the removal of interaction or localization domains by alternative splicing. Alternative splicing can also regulate gene expression by splicing transcripts into unproductive mRNAs targeted for degradation. To fully understand the scope of alternative splicing, we must also determine how many of the predicted splice variants represent functional forms. Comparisons of alternative splicing between human and mouse genes show that predominant splice variants are usually conserved, but rare variants are less commonly shared. Evolutionary conservation of splicing patterns suggests functional importance and provides insight into the evolutionary history of alternative splicing. The definition of functional splicing has evolved to match our increased understanding of gene expression.
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Alternative splicing is now commonly thought to affect more than half of all human genes. Recent studies have investigated not only the scope but also the biological impact of alternative splicing on a large scale, revealing that its role in generating proteome diversity may be augmented by a role in regulation. For instance, protein function can be regulated by the removal of interaction or localization domains by alternative splicing. Alternative splicing can also regulate gene expression by splicing transcripts into unproductive mRNAs targeted for degradation. To fully understand the scope of alternative splicing, we must also determine how many of the predicted splice variants represent functional forms. Comparisons of alternative splicing between human and mouse genes show that predominant splice variants are usually conserved, but rare variants are less commonly shared. Evolutionary conservation of splicing patterns suggests functional importance and provides insight into the evolutionary history of alternative splicing.
Introduction
It is now well established that many, if not most, human genes are alternatively spliced. Although estimates vary between studies, and increase as more data become available (reviewed in [1] ), the prevalence of alternative splicing raises intriguing questions. How much of the observed alternative splicing is functional? What roles does alternative splicing play? How did alternative splicing evolve and what selective advantages does it confer?
The definition of functional splicing has evolved to match our increased understanding of gene expression. At the same time that we realized the human genome has far fewer genes than expected, we began to appreciate the full extent of alternative splicing. Many concluded that alternative splicing led to proteome expansion, bridging a perceived complexity gap. However, complexity is not determined simply by proteome size; it also encompasses interactions and regulation. Recently, we have begun to better understand alternative splicing as a regulatory process, contributing to biological complexity through its ability to control the expression of proteins. A recent paper provides a modern definition of functional splicing: ''An mRNA variant can be defined as being 'functional' if it is required during the life-cycle of the organism and activated in a regulated manner'' [2 ] . In some cases, functional splice forms may not even be required in their own right, but their production is required to regulate active protein levels. Moreover, the meaning of 'required' can be generalized by defining functional splicing as that which conveys a selective advantage.
Well before alternative splicing was known to be widespread, studies showed that control of splicing could act as a general on/off switch to regulate gene expression [3] . Work on mRNA stability in Caenorhabditis elegans indicated that alternative splicing of serine/argininerich (SR) proteins, themselves involved in alternative splicing, could regulate their expression [4] . Recently, the combination of large-scale studies, enabled by the large data sets now available (Table 1) , and studies of individual alternatively spliced genes has shed light on the regulatory roles and evolution of alternative splicing.
Large-scale studies of the regulatory impact of alternative splicing
The first large-scale studies of alternative splicing were inventory-style analyses, designed to determine the extent of alternative splicing. The results of those surveys, that alternative splicing is common in many eukaryotes, have inspired a spate of recent studies addressing the regulatory impact of alternative splicing.
Several studies ask whether alternative splicing occurs preferentially in certain classes of genes. An early analysis of 50 randomly chosen alternatively spliced human genes found that many were specific to the immune and nervous systems, and were commonly involved in signal transduction [5] . However, the FANTOM2 analysis of alternatively spliced mouse transcripts found that these functional categories were no more prevalent among alternatively spliced genes than other genes [6] . The FAN-TOM2 analysis did find that gene ontology (GO) terms [7] related to enzymes or enzymatic functions were underrepresented among alternatively spliced mouse genes, but an analysis of the alternative splicing described in reviewed RefSeq entries found that alternatively spliced genes function mostly as enzymes, signal transducers and receptors [8] . In addition to these apparently conflicting results, the usefulness of these studies is limited by the lack of a clear biological hypothesis. If alternative splicing is found to preferentially affect a certain functional class of gene, it could be explained in several different ways. For example, there may have been duplication of gene families whose ancestral members happen to have been alternatively spliced or a recent functional proliferation might have made use of alternative splicing for protein diversity.
A related genre of large-scale analyses has also been performed: classification of the functional components of genes affected by alternative splicing. In many cases, understanding which components are affected (transmembrane regions, signal peptides, catalytic domains, etc.) and how they are affected (added, removed, altered) can provide important and easily interpretable biological conclusions. Taking this approach, Resch et al. [9] identified a set of functional domains that are removed more often than would be expected given the frequencies of each domain and of alternative splicing, including KRAB, ankyrin repeat and tubulin-binding domains. 56% of the members of this functionally diverse set fall into the higher level category of protein-interaction domains, yet this is no more than would be expected, given that this category is very common (64% of Swiss-Prot domains studied). They further showed, by way of several interesting examples, how this type of analysis leads to testable hypotheses regarding these isoforms' regulatory functions, as described below.
A final regulatory theme that has been explored in largescale studies is localization, especially membrane association. Several genes have been shown to produce both [85] soluble and membrane-associated protein isoforms by selective incorporation of exons encoding transmembrane regions. In particular, several tumor necrosis factor receptor (TNFR) genes are alternatively spliced in a regulated manner to produce either soluble or membrane-associated signal-transducing forms [10] [11] [12] [13] [14] [15] . Xing et al. [16] showed that alternative inclusion/exclusion of membrane-spanning regions is a common outcome of alternative splicing, a result that was corroborated in a mouse-specific study [17] .
Detailed studies of alternative splicing reveal regulatory functions ranging from molecular interaction to cell apoptosis
Pioneering, detailed studies of specific alternatively spliced genes revealed that splicing could be used to regulate biological processes. Among the best-characterized classic examples are Drosophila Sex lethal, which binds its own pre-mRNA in female flies to repress inclusion of a male-specific exon that would introduce a premature stop codon (reviewed in [18] ), and human Bcl-x, which is spliced to form either a short, pro-apoptotic protein or a long, anti-apoptotic protein [19] . These classic biochemical investigations have been followed by hundreds more that use a wide variety of methods to discover and detail the implications of alternative splicing for specific genes. As mentioned above, Resch et al. [9] demonstrate how appropriately designed, broad studies can lead to very specific and interpretable results. For example, they showed that, for the genes encoding the Kruppel family of transcription factors, alternative splicing preferentially removes the protein-interaction domain(s) and not the DNA-binding domains. Thus, the full-length isoforms are predicted to bind DNA and be responsive to interaction partners. Shorter isoforms that lack the protein-interaction domain(s) may bind DNA, but would be insensitive to interaction partners [9] .
In many cases, alternative isoforms differ by small alterations of functional elements or domains, not by complete removal of functional elements [20] . In these cases, consideration of protein isoforms as simply the sum of their parts may not be sufficient to predict the biology of the resultant isoforms. For example, it was recently shown that Piccolo (Aczonin), a cytomatrix component of the presynaptic active zone, is alternatively spliced to remove a nine-residue region within its Ca 2þ -binding C 2 A domain [21 ] . The shorter Piccolo isoform binds Ca 2þ with higher affinity, but is incapable of the Ca 2þ -dependent dimerization that occurs in the longer form. As revealed by NMR analysis, the nine extra residues of the long form unexpectedly displace a b strand present in the short form, providing a structural basis for the different biochemical properties of these isoforms.
Similar studies were performed to investigate the structural basis of the ligand-binding specificity of fibroblast growth factor receptor 2 (FGFR2) isoforms [22 ,23] . Normal mammalian development and homeostasis depend on correct, specific interactions between the 23 known fibroblast growth factors (FGFs) and their receptors. In humans, several craniosynostosis syndromes, including Apert syndrome, are caused by mutations in FGFRs that abolish or alter ligand specificity [24] . For FGFR2, ligand specificity is achieved in part via tissuespecific alternative splicing of part of one of its three Iglike domains, D3. FGFR2 co-crystal structures with FGF2 and FGF10 revealed that the alternatively spliced region of D3 lies in a binding cleft containing critical determinants of ligand specificity. These studies of Piccolo and FGFR2 underscore the importance of detailed structural analysis of the diversity generated by alternative splicing.
Over the past several years, scores of detailed studies have shown how alternative splicing is used in many organisms to regulate a great diversity of essential biological processes. For example, programmed cell death of lymphocytes must be tightly regulated for proper immune system function. In unactivated lymphocytes, which are insensitive to apoptotic stimulant, the alternatively spliced TNFR gene TNFRSF25 expresses at least 10 mRNA isoforms with truncated open reading frames (ORFs) [15] . After lymphocyte activation, a precise splicing shift results in production of a single, full-length isoform harboring the death domain, which renders the cells susceptible to apoptosis.
Another life-or-death regulatory role for alternative splicing is in host-pathogen interactions. In tobacco, regulated expression of N gene isoforms confers resistance to tobacco mosaic virus (TMV) infection [25] . In response to TMV infection, tobacco generates a stereotypical temporal profile of ratios of N alternative isoforms. This profile is necessary for effective TMV response. Expression of either isoform, or both, without the correct temporal regulation fails to confer proper TMV resistance. Conversely, in the final stages of the adenovirus replication cycle in human cells, the host splicing machinery is hijacked to produce the late category of adenovirus gene products via alternative splicing [26, 27] .
Finally, a virtually unexplored arena of alternative splicing regulation is deciphering roles for the roughly 20% of alternative isoforms that do not change protein coding potential. Many large-scale studies filter these in an early preprocessing step. Alternative mRNAs differing only in their 5 0 untranslated region (UTR) are common and their expression may be regulated through alternative promoter usage [28 ] . 3 0 UTR elements may control mRNA subcellular localization, stability and translational efficiency [29, 30 ], although the signals responsible for this layer of regulation are incompletely understood.
RUST: regulated unproductive splicing and translation
One common outcome of alternative splicing is downregulation of the function of a gene by the production of non-functional isoforms of the active gene product. This can be accomplished by the alteration of domains necessary for catalysis, localization or association with other macromolecules, as discussed above. A distinct mechanism is the use of alternative splicing to induce nonsensemediated mRNA decay (NMD) [4, 31, 32] . Gene expression can be regulated post-transcriptionally by the production of splice forms that will be degraded by NMD rather than translated into protein, a process we have termed regulated unproductive splicing and translation (RUST) [33 ,34 ] .
NMD is an RNA surveillance function that recognizes mRNAs containing premature termination codons (PTC þ mRNAs) and targets the transcripts for destruction rather than translation into protein (reviewed in [35] ). Nonsense and frameshift mutations, errors in pre-mRNA processing and alternative splicing are among the many sources of PTC þ mRNAs.
One example of the role of NMD in clearing the products of mis-splicing is observed in the splicing of FGFR2 (described above). Mutually exclusive inclusion of exons IIIb or IIIc, which encode critical determinants of ligandbinding specificity, is necessary for directional signal transduction. The cell creates correct mRNAs with a single alternative exon, but also produces mRNA species containing both or neither. These erroneous products are frameshifted and contain PTCs [36]; they appear to be degraded by NMD. In this case, NMD helps ensure the fidelity of directional signal transduction by preventing potentially harmful by-products of splicing from being translated.
The process of NMD is conserved in all eukaryotes in which it has been examined (reviewed in [37]), but many details of PTC recognition and mRNA degradation remain to be elucidated. The mechanism of PTC recognition differs between mammals and Saccharomyces cerevisiae, and it is not as well established how PTCs are recognized in the transcripts of Drosophila melanogaster and C. elegans [38 ] . In mammals, recognition of PTCs is intimately related to pre-mRNA splicing: a termination codon is recognized as premature if it is more than about 50 nucleotides upstream of the site of removal of an intron [35] .
The elucidation of this simple rule determining whether a human mRNA is subject to NMD has allowed largescale computational analyses of alternatively spliced transcripts. Studies of alternative splicing inferred from expressed sequence tags (ESTs) revealed that 45% of human alternatively spliced genes produce at least one mRNA isoform that contains a PTC and thus is a target of NMD [33 ] . A similar computational screen of annotated alternatively spliced protein isoforms within Swiss-Prot revealed that 7.9% of 1463 human alternatively spliced genes amenable to analysis have at least one isoform that is predicted to undergo degradation by NMD [34 ] . The surprisingly large proportion of alternative splicing that appears to destine mRNAs for degradation rather than translation led to the proposal that RUST is a widespread and generally applicable mechanism of post-transcriptional gene repression.
The kinetics and efficiency of NMD, and the amount and disposition of protein that may be translated before mRNA decay are incompletely understood and are active areas of research [35, 39 ]. The accuracy of computational predictions of the effect of NMD, generated from simple models of PTC recognition, is thus limited; NeuYilik et al.
[40] review the limitations of this model in predicting NMD targets and functional consequences. Nonetheless, several recent studies have added to a growing list of experimentally characterized cases that validate the proposed broad role of RUST gene regulation. Polypyrimidine tract binding protein (PTB), a regulator of alternative splicing, was shown to autoregulate its protein level through RUST (Figure 1 ). When PTB protein levels increase, the protein alters splicing of its own pre-mRNA, favoring exclusion of exon 11 and thereby introducing a frameshift and thus a PTC. This PTC-containing mRNA is present at very low steadystate levels, which increase approximately tenfold when Upf1, an essential component of NMD, is knocked down by RNA interference (RNAi) [41 ] .
Similarly, the human alternative splicing regulatory SR-like protein TRA2-BETA autoregulates its level by inducing inclusion of a PTC-containing exon in its mRNA when the protein level is increased [42] . Another example is TIAR, a protein that affects regulation of both translation and alternative splicing events. TIAR is downregulated by inclusion of a PTC-containing exon, forming a labile mRNA that is stabilized by treatment with the NMD inhibitor cycloheximide, suggesting degradation by NMD. In this case, RUST is not autoregulatory. The PTC þ splice form has not been demonstrated to be induced by TIAR protein itself, but by the related TIA-1 protein [43] .
RUST may also occur in plants, although the process of NMD is not well characterized in the plant kingdom. The Arabidopsis thaliana AtGRP7 gene, which encodes an RNA-binding protein that can regulate alternative splicing, is under transcriptional regulation with circadian oscillation. Its expression is also post-transcriptionally autoregulated; AtGRP7 protein binds to its pre-mRNA (as well as the pre-mRNA of the related RNA-binding protein AtGRP8) and activates a cryptic splice site within the single intron (of each AtGRP7 and AtGRP8), resulting in a transcript with a PTC. The transcripts are rapidly degraded in a process that can be inhibited by cycloheximide [44] .
Several well-characterized examples of RUST, including those described above, as well as autoregulation of the SR protein SC35 [45] , involve genes that are explicitly involved in regulation of splicing. Whether this regulatory mechanism is used disproportionately by splicing factors or whether this observation reflects acquisition bias remains to be seen. Observations from our laboratory (D Soergel, SE Brenner, unpublished) suggest that RUST affects many protein groups other than splicing factors. Other examples, such as ribosomal proteins in S. cerevisiae [31] and C. elegans [46] , and AUF1, a modulator of RNA stability [47] , implicate RUST in regulation of proteins generally not involved in splicing. The ABCC4 gene, a multidrug resistance associated transporter, recently has been shown to undergo alternative splicing to produce isoforms containing one or two PTC-containing exons. These PTC þ transcripts are degraded by NMD [48] .
In several of the examples discussed above, analysis of orthologous and paralogous sequences suggests that splicing to generate PTC þ alternative isoforms, and thus RUST regulation, is conserved across species and across protein families. For PTB, the sequence and upstream regulatory elements of alternatively included PTCcontaining exon 11 are very similar in the Fugu rubripes ortholog of the analyzed human gene, as well as in a human neuronal-specific paralog [41 ] . Mouse and monkey orthologs of human ABCC4 share highly conserved PTC-containing exons that are orthologous to the alternatively included exons of ABCC4 [48] . The chicken ortholog of the human TIAR gene likewise has an orthologous PTC þ exon [43] .
Strong evidence of conservation of RUST is found in the CDC-like kinases (Clks), which phosphorylate SR proteins to regulate splicing [49] . Alternative splicing to exclude exon 4, introducing a frameshift and PTC, is conserved among three human paralogs (Clk1-3), the three orthologs of these genes in mouse and even the sole copy of the gene in the sea squirt Ciona intestinalis [34 ] . For Clk1, RUST appears to regulate the protein through an indirect feedback mechanism. Clk1 has been shown to indirectly modify splicing of its own transcript, most likely through phosphorylation of SR proteins [50] . Thus, as a variation of the autoregulatory circuits described above, increased Clk1 activity results in changes in the activity of one or more SR proteins, resulting in altered splicing of Clk1 pre-mRNA to favor a PTC þ transcript that is predicted to undergo NMD [34 ] . [45] . The ability to use alternative splicing to regulate the factors that control alternative splicing of other gene products suggests the possibility of regulatory cascades of alternative splicing. An upstream splicing (or phosphorylation) event might lead to changes in the splicing of a few splicing regulatory factors that can affect a broad range of substrates. Thus, RUST may represent both a mode of regulation by alternative splicing and a mechanism of regulation of alternative splicing. Such a cascade of regulated splicing events would enable limited upstream input to effect a large change in the proteome.
Function versus noise
How much of the alternative splicing predicted by ESTs is functional, rather than noise? Some noise is merely data contamination, but noise can also be of biological origin. Rare transcripts representing splicing errors could arise from mutations disrupting splice signals. Mutations in intronic regions can have significant effects on splicing, yet are invisible after intron removal. Errors could also come from malfunction of the splicing machinery itself. Though the spliceosome distinguishes true splice sites from nearby cryptic sites with impressive fidelity, splice site recognition is a complex process and errors must occur at some low rate. EST libraries contain millions of transcript sequences, so even extremely rare events may be represented. Further noise could come from neutral splicing decisions, with no significant effect on the cellular function [51] .
To avoid noise from data contamination, the reliability of the data set can be increased by filtering ESTs with poor alignment to the genome sequence, checking for good donor and acceptor splice sites, and ignoring ESTs likely to represent incompletely processed transcripts, as summarized by Modrek and Lee [52] . Some studies also filter splicing events that are seen only in a few ESTs. All filtering can exclude legitimate splice forms, including rare forms or forms produced by events that are indistinguishable from incomplete processing, such as intron retention [53] . An extension of this concept uses a statistical model to see whether a splice form is likely to occur above some frequency cutoff, based on its occurrence in the observed data [54] . Further support for function comes from tissue or temporal specificity of an isoform [55] . Specific appearance of an isoform is often taken as evidence that its production is regulated and this regulation could suggest function. However, differential expression need not be functional. The cell might have a background level of producing non-functional mRNAs; different conditions in various tissues could lead to differences in this background splicing.
Conservation and evolution of alternative splicing
With genome sequence and EST libraries now available for multiple organisms, many recent studies focus on cross-species conservation of alternative splicing, particularly between human and mouse. Evolutionary conservation over long time periods suggests positive selection and implies function; thus, it can be used both to study the evolution of alternative splicing and to filter noise. The flurry of reports in the past year seem at first glance to introduce more uncertainty, as estimates of the conservation of alternative splicing between human and mouse range from 8% [54] to 98% [56 ] . To untangle the situation, it is important to consider the data sets, methods and definitions used by each group ( Table 2) .
The most straightforward approach to studying conservation of alternative splicing uses EST information from two species to identify equivalent alternative splice events in orthologous genes [57] . EST libraries are incomplete, so this method underestimates the extent of conservation. Two groups have increased the estimate of conserved alternative splicing by using statistics to extrapolate from genes with high EST coverage [54, 58] . Missing EST data can also be recovered by examining the underlying genome sequence. If ESTs show inclusion of a cassette exon in human, but not mouse, examination of the genomic sequence might show that the exon sequence is indeed conserved in the correct location, with acceptable splice sites [56 ,59,60] . This does not confirm that the exon is ever included; it could represent a recent loss of splicing. Some groups choose to rely solely on experimentally characterized splicing events, not ESTs, leading to small, high-confidence data sets that can be studied in detail but may not be completely representative [61] .
Many of the analyses distinguish between the major or predominant splice form, and the minor or rare splice form of a gene. These distinctions are based on the number of ESTs found for each splice form; although precise definitions vary, 'major' is often defined as the splice form found in at least half the ESTs for the gene Table 2 Studies of alternative splicing conservation between human and mouse. show that there are meaningful differences between these classes of alternative splice forms.
Despite differences in the actual frequencies observed by different groups, there is overwhelming evidence that minor forms are less conserved than major forms. Conservation of major forms can be as high as 98%, equivalent to the conservation level of constitutive exons, in the case of cassette exons [56 ] and overall seems to be at least two-thirds [54, 58] . Minor forms are only conserved a fraction, perhaps one-quarter, of the time [54,56 ,58] . Although this may indicate that some minor forms do indeed represent noise, minor forms are generally supported by multiple ESTs and thus may represent legitimate species-specific splicing. On the other hand, statistical extrapolation shows that conservation of minor forms may be as high as 60% [58] and further EST evidence may confirm that a substantial number of minor forms are conserved. More evidence that the distinction between major and minor forms is biologically meaningful comes from the observation that the major form in human is usually the major form in mouse as well. Similarly, minor forms in one species are generally also minor forms in the other species [56 ] .
The results also show that alternative splicing conserved between species differs from non-conserved alternative splicing in significant ways. Conserved alternative splicing events are much more likely than random to preserve frame, especially in minor forms, whereas constitutive exons and non-conserved alternative splicing are no more likely to preserve frame than expected randomly [60] . Similar results show that conserved cassette exons are less likely to have stop codons or introduce frameshifts than non-conserved cassette exons. Interestingly, the same result held when looking at non-conserved cassette exons with at least five ESTs [2 ] .
Also of interest is the ancestral state of alternatively spliced genes, which may not be equivalent to the distinction between major and minor forms in all cases. By aligning alternatively spliced human genes with their prokaryotic and yeast orthologs, Kondrashov and Koonin [62] showed that, in 48 of 73 cases, the longer form was ancestral; this is most often associated with exon skipping in the derived form. Although it may be difficult for derived forms to gain novel coding sequence as exon insertions, some of the insertions may serve to introduce PTCs for regulation by RUST. Cases of ancestral short forms show more evidence of de novo emergence than exon duplication [62] , although exon duplication does play a significant role in gene evolution [63] . In humans, new exon sequence can also arise from Alu repeats inserted in introns. The Alu sequence includes motifs that can be recognized as splice sites, causing the repeat to act as an alternative exon [64] . Furthermore, single mutations in these sequences can result in constitutive inclusion [65 ] . Although these mutations may be detrimental, they provide a source of potentially advantageous novel forms.
New experimental methods quantify splicing on a large scale Recent experimental innovations can help confirm that an isoform actually exists and is produced in a regulated way. A microarray using exon junction sequences was used to examine 10 000 human genes in 52 tissues, to determine tissue specificity of alternative splicing events [66 ] . Because of practical constraints, only known splice junctions are included on the array. All-exon probe arrays allow limited discovery of new forms. For instance, if an exon is skipped in some conditions, it will be less abundant than constitutive exons of the same gene. Exon probe arrays are still unable to show specific patterns of exon use, such as mutually exclusive exons. Microarrays using a combination of exon and junction sequences have been used to determine the relative abundance of known isoforms [67] . The actual isoforms produced by the Drosophila DSCAM gene, a popular example of extensive combinatorial alternative splicing, were assessed using an exon probe microarray and single-cell RT-PCR [68] . Arrays can show the frequencies of different exons or splice junctions, but may not indicate which combinations occur in individual transcripts. Single-molecule methods such as polymerase colonies (polonies) detect each individual mRNA and can show exon use correlations, rare isoforms and novel splice forms [69 ] . Unlike EST abundance, which gives a very crude approximation of actual transcript levels, single-molecule experiments can pinpoint expression levels. A transcript produced only once in experiments from hundreds of cells could be identified as a rare missplicing event. Other single-molecule techniques, such as 'BEAMing', in which DNA molecules are amplified and attached to magnetic beads for sorting [70] , could perhaps be applied to alternative splicing with similar results.
Conclusions
The prevalence of alternative splicing shows that it may play important roles in many biological processes, but many questions must be answered before its true scope and significance are known. Recent work has advanced our understanding of alternative splicing; at the same time, it has raised interesting and important questions.
By affecting regions involved in interaction or localization, alternative splicing can generate isoforms that differ in subtle or dramatic ways. Many of these isoforms have been shown to play key regulatory roles in a diverse array of biological processes. Functional coupling of alternative splicing and NMD, in which transcripts are spliced into forms that are targets for NMD, is another mode of regulation. Examples of this potentially widespread mechanism of gene regulation can be found in fungi, animals and perhaps plants, indicating either that the process was found in their common ancestor or that it has evolved independently multiple times. Indeed, in S. cerevisiae, as many characterized examples of alternative splicing are used for RUST (via regulated intron retention) as are potentially used for proteome diversity [71] . Although some fraction of the predicted human NMD targets probably represent splicing errors, and others may escape NMD and play other roles in the cell [40] , the wide conservation of RUST indicates that it may be one of the major roles of alternative splicing.
Although EST data show that more than half of all human genes are alternatively spliced, the fraction that can be considered functional is unknown. Some of the transcripts almost certainly represent biological noise. The best evidence of function comes from individual experiments showing the beneficial effect of regulation, but this approach is impractical or even impossible on a large scale [51] . Even expression data from microarray experiments only provide second-hand evidence of regulation of a given form. In the absence of a direct test of selective advantage, the nearest facsimile is to learn from the experiment of evolution. The studies discussed above show that approximately a quarter of minor alternative splice forms are conserved between human and mouse. What should be concluded about the non-conserved forms? Some may represent species-specific functional splicing; some may be noise. The transcripts representing aberrant splicing may not be functional, but the existence of such noise might be evidence of flexibility of the splicing mechanism that could enable the evolution of new functional forms.
Alternative splicing has almost certainly increased its scope over the course of evolution; its functional importance may have evolved to fill new roles as well. As Jacob noted, nature is a tinkerer [72] . In alternative splicing, which almost certainly evolved by tinkering with the splicing machinery and its modulators, nature has found an efficient tool for tinkering both with proteins and with regulation of gene expression.
